Adding thrombolytic therapy to standard anticoagulation with heparin did not significantly improve overall survival at 3 months in patients with acute symptomatic pulmonary embolism. Dr. David Jimenez discusses the results. See the related story at http://tinyurl.com/3rpqbcu
All Comments